A New Hope for Weight Management?
The UK is keenly observing the arrival of retatrutide, a novel dual-action therapy showing impressive results in clinical trials for weight loss . This new compound, produced by Eli Lilly, works by modulating both GLP-1 and GIP receptors, potentially offering greater lessening in body weight comp